Company Profile

Sanofi Stock Price, News & Catalysts

Ticker:
SNY
Exchange:
NASDAQ
Sector:
Generics, Antibody Drugs, CNS, Gene Therapy, Novel Therapies, Biopharma, Vaccines
Location:
France and listed in the U

Stock performance

46.06 USD (-2.25%)

Close

Last updated: November 19, 2026

102B USD

Market cap

Why the stock is moving

As of Nov 19, 2026, SNY closed down 2.25% at $46.06. No new same-company headline was identified in the current news window.

Company overview

Global Biopharmaceutical Company

Sanofi is a global biopharmaceutical company with major businesses in specialty medicines and vaccines. Its research and commercial portfolio is concentrated in immunology, rare diseases, hematology, neurology, oncology, and infectious-disease prevention.

Dupixent-Led Immunology Franchise

Dupixent, developed with Regeneron, blocks interleukin-4 and interleukin-13 signaling through IL-4 receptor alpha. It is used across multiple type 2 inflammatory diseases and anchors Sanofi's immunology business, while the alliance is expanding into next-generation immunology antibodies.

Rare Disease and Hematology Portfolio

Sanofi markets therapies including ALTUVIIIO and Qfitlia for hemophilia, Nexviazyme for Pompe disease, Xenpozyme for acid sphingomyelinase deficiency, and Cablivi for acquired thrombotic thrombocytopenic purpura. These products combine replacement, enzyme, and targeted treatment approaches across specialized patient populations.

Oncology and Specialty Medicines

The specialty portfolio includes Sarclisa for multiple myeloma, Ayvakit for gastrointestinal stromal tumors and systemic mastocytosis, and Rezurock for chronic graft-versus-host disease. Sanofi uses internal development and business development to build positions in focused oncology and immune-mediated diseases.

Vaccines and Respiratory Prevention

Sanofi operates a broad vaccines business spanning influenza, pediatric combination vaccines, meningococcal disease, and travel or endemic infections. Its respiratory-prevention portfolio also includes Beyfortus, developed with AstraZeneca, for prevention of respiratory syncytial virus disease in infants.

Broad Late-Stage Pipeline

The company maintains a large clinical pipeline with numerous Phase 3 and submitted programs. Development priorities include expanding established medicines into additional populations and advancing new mechanisms intended to support growth beyond the current Dupixent franchise.

Future catalysts

    Recent news

    1. 01
    2. 02
    3. 03
    4. 04
    5. 05

    Similar stocks

    Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.

    Frequently Asked Questions

    What is the current stock price of Sanofi (SNY)?

    Sanofi (SNY) most recently closed at 46.06 USD, a -2.25% move versus the previous session.

    What is the market cap of Sanofi (SNY)?

    Sanofi currently has a market capitalization of 102B USD on BioPharmSignal.

    What does Sanofi do?

    Global Biopharmaceutical Company Sanofi is a global biopharmaceutical company with major businesses in specialty medicines and vaccines. Its research and commercial portfolio is concentrated in immunology, rare diseases, hematology, neurology, oncology, and infectious-disease prevention. Dupixent-Led Immunology Franchise Dupixent, developed with Regeneron,...

    On which exchange is SNY stock listed?

    Sanofi (SNY) is associated with NASDAQ, France and listed in the U, Generics, Antibody Drugs, CNS, Gene Therapy, Novel Therapies, Biopharma, Vaccines.

    What is IL-4?

    Dupixent-Led Immunology Franchise Dupixent, developed with Regeneron, blocks interleukin-4 and interleukin-13 signaling through IL-4 receptor alpha.

    Which conditions is Sanofi targeting with IL-4?

    Sanofi is associated with oncology, immunology, rare disease based on its company overview and current catalyst commentary.

    What is Global?

    Global Biopharmaceutical Company Sanofi is a global biopharmaceutical company with major businesses in specialty medicines and vaccines.

    What is Biopharmaceutical?

    Global Biopharmaceutical Company Sanofi is a global biopharmaceutical company with major businesses in specialty medicines and vaccines.